Domov › Mnohonásobný myelóm › Illinois

Klinické štúdie Mnohonásobný myelóm v štáte Illinois

31 štúdií pre Mnohonásobný myelóm hľadá účastníkov v zariadeniach v štáte Illinois.

Mestá v štáte Illinois

Oficiálny text štúdie (anglicky)

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
a 13 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06948084

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

University of Chicago Medical Center /ID# 278863, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07409246

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Research Site, Chicago
Research Site, Park Ridge

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07391657

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

University of Chicago Medical Center, Chicago

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT04973605

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Rush University System for Health, Chicago

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

City of Hope Chicago, Zion

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07258511

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

University Of Illinois Medical Center, Chicago
Loyola University Medical Center, Maywood

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05552222

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Northwestern University, Chicago
University of Chicago, Chicago

Prebieha náborFáza 4

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05201781

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

University of Chicago Medicine Comprehensive Cancer Center, Chicago

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05789303

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Cancer Treatment Centers of America-Chicago, Chicago

Prebieha náborFáza 2

Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT02693535

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Northwestern Memorial Hospital, Chicago
University of Chicago Medical Center, Chicago

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06297226

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

University of Illinois at Chicago, Chicago

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT05344833

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Endeavor Health - Swedish Hospital, Chicago
Endeavor Health - Evanston Hospital, Evanston
Endeavor Health - Glenbrook Hospital Ambulatory Care Center, Glenview
a 6 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

OSF Saint Anthony's Health Center, Alton
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
a 40 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT04566328

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Research Site, Chicago

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Research Site, Chicago

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Loyola University Medical Center, Maywood

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT07280013

Mosaic Trial for Stem Cell Transplant Recipients

Northwestern University Feinberg School of Medicine, Chicago

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06960993

Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma

Loyola University Chicago, Maywood

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT07236502

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Hope And Healing Cancer Services /ID# 268536, Hinsdale

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT05650632

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

Personalized Autologous Transplant for Multiple Myeloma

University Illinois Chicago, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT04483206

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Saint Anthony's Health, Alton
Rush - Copley Medical Center, Aurora
Saint Joseph Medical Center, Bloomington
a 41 ďalších

Prebieha náborFáza 3

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT05561387

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

University of Chicago, Chicago
University of Illinois Medical Center at Chicago, Chicago

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT05243797

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

University of Chicago, Chicago

Prebieha náborFáza 1

Vek 13 a viac · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT04771572

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

University of Chicago Medical Center, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 4. 2026 · NCT05862012

Hypofractionation (Radiation) Trial for Multiple Myeloma

The University of Chicago Comprehensive Cancer Center, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 3. 2026 · NCT06270888

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Northwestern, Chicago

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 24. 3. 2026 · NCT04988555

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Northshore University Health System, Evanston

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 2. 2026 · NCT05974150

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

City of Hope at Chicago, Zion

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT07225738

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

University of Illinois Cancer Center, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 12. 2025 · NCT05192122

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.